Skip to main content
Clinical Trials/KCT0008667
KCT0008667
Recruiting
未知

Comparison of efficacy and safety of remimazolam and propofol: multicenter prospective randomized trial

Yonsei University Health System, Gangnam Severance Hospital0 sites394 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the digestive system
Sponsor
Yonsei University Health System, Gangnam Severance Hospital
Enrollment
394
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Yonsei University Health System, Gangnam Severance Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\) Men or women between the ages of 20 and 70
  • 2\) Subjects who have voluntarily decided to participate after hearing the explanation of the clinical trial process and signed the consent form
  • 3\) All subjects requiring ultrasound endoscopy
  • 4\) Subjects with class I or II in the American Society of Anesthesiology (ASA) risk assessment

Exclusion Criteria

  • 1\) Pregnant woman
  • 2\) Those who are susceptible to remimazolam, propofol or benzodiazepine drugs (midazolam), or those who are susceptible to eggs, beans, etc
  • 3\) subjects undergoing adrenocortical or chronic steroid therapy or porphyria
  • 4\) Subjects who are expected to have difficulty with airway intubation (subjects who have difficulty opening their mouths wide or have a thick neck and short neck)
  • 5\) a subject diagnosed with sleep apnea
  • 6\) Subjects with a history of reported risk cases during sedative endoscopy in the past
  • 7\) Subjects with severe renal disease (serum creatinine \>2 mg/dL)
  • 8\) Subjects with severe heart disease (subjects with NYHA class III or IV)
  • 9\) subjects who wish to receive an endoscopy without sincerity
  • 10\) Subjects who cannot or are not willing to prepare an automatic test protocol or who do not agree to provide information;

Outcomes

Primary Outcomes

Not specified

Similar Trials